Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial.

Cassano P, Petrie SR, Mischoulon D, Cusin C, Katnani H, Yeung A, De Taboada L, Archibald A, Bui E, Baer L, Chang T, Chen J, Pedrelli P, Fisher L, Farabaugh A, Hamblin MR, Alpert JE, Fava M, Iosifescu DV.

Photomed Laser Surg. 2018 Oct 20. doi: 10.1089/pho.2018.4490. [Epub ahead of print]

PMID:
30346890
2.

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.

Ionescu DF, Bentley KH, Eikermann M, Taylor N, Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, Cusin C.

J Affect Disord. 2019 Jan 15;243:516-524. doi: 10.1016/j.jad.2018.09.037. Epub 2018 Sep 17.

PMID:
30286416
3.

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).

Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI.

Mol Psychiatry. 2018 Oct 3. doi: 10.1038/s41380-018-0256-5. [Epub ahead of print]

PMID:
30283029
4.

Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature.

Ionescu DF, Felicione JM, Gosai A, Cusin C, Shin P, Shapero BG, Deckersbach T.

Harv Rev Psychiatry. 2018 Nov/Dec;26(6):320-339. doi: 10.1097/HRP.0000000000000179.

PMID:
29465479
5.

Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1].

Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M.

J Affect Disord. 2018 Feb;227:198. doi: 10.1016/j.jad.2017.10.040. Epub 2017 Nov 5. No abstract available.

PMID:
29100152
6.

Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).

Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, Papakostas GI.

Brain Stimul. 2018 Jan - Feb;11(1):75-84. doi: 10.1016/j.brs.2017.09.010. Epub 2017 Sep 23.

PMID:
29030111
7.

Efficacy of Ziprasidone Augmentation of Escitalopram for Cognitive Symptoms of Major Depressive Disorder.

Iovieno N, Shelton RC, Petrie SR, Cusin C, Fava M, Papakostas GI.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 16m10920. doi: 10.4088/JCP.16m10920.

PMID:
28749091
8.

A randomized controlled trial of ganaxolone in posttraumatic stress disorder.

Rasmusson AM, Marx CE, Jain S, Farfel GM, Tsai J, Sun X, Geracioti TD, Hamner MB, Lohr J, Rosse R, Summerall L, Naylor JC, Cusin C, Lang AJ, Raman R, Stein MB.

Psychopharmacology (Berl). 2017 Aug;234(15):2245-2257. doi: 10.1007/s00213-017-4649-y. Epub 2017 Jul 1.

PMID:
28667510
9.

Drs Ionescu and Cusin Reply.

Ionescu DF, Cusin C.

J Clin Psychiatry. 2017 Jan;78(1):e72. doi: 10.4088/JCP.16lr11210a. No abstract available.

10.

Acute deep brain stimulation changes in regional cerebral blood flow in obsessive-compulsive disorder.

Dougherty DD, Chou T, Corse AK, Arulpragasam AR, Widge AS, Cusin C, Evans KC, Greenberg BD, Haber SN, Deckersbach T.

J Neurosurg. 2016 Nov;125(5):1087-1093. Epub 2016 Feb 19.

PMID:
26894459
11.

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.

Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M.

J Affect Disord. 2017 Jan 15;208:6-14. doi: 10.1016/j.jad.2016.08.029. Epub 2016 Oct 1. Erratum in: J Affect Disord. 2017 Oct 27;227:198.

PMID:
27736689
12.

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.

Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C.

J Clin Psychiatry. 2016 Jun;77(6):e719-25. doi: 10.4088/JCP.15m10056.

PMID:
27232360
13.

Minimum Effective Doses of Succinylcholine and Rocuronium During Electroconvulsive Therapy: A Prospective, Randomized, Crossover Trial.

Mirzakhani H, Guchelaar HJ, Welch CA, Cusin C, Doran ME, MacDonald TO, Bittner EA, Eikermann M, Nozari A.

Anesth Analg. 2016 Sep;123(3):587-96. doi: 10.1213/ANE.0000000000001218.

PMID:
26967896
14.

A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder.

Ionescu DF, Fava M, Kim DJ, Baer L, Shelton RC, Cusin C.

Ther Adv Psychopharmacol. 2016 Feb;6(1):4-12. doi: 10.1177/2045125315618621.

15.

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.

Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor N, Eikermann M, Durham K, Swee MB, Chang T, Dording C, Soskin D, Kelley J, Mischoulon D, Brown EN, Fava M.

Aust N Z J Psychiatry. 2017 Jan;51(1):55-64. doi: 10.1177/0004867416631828.

PMID:
26893373
16.

Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study.

Mischoulon D, De Jong MF, Vitolo OV, Cusin C, Dording CM, Yeung AS, Durham K, Parkin SR, Fava M, Dougherty DD.

J Psychiatr Res. 2015 Nov;70:98-105. doi: 10.1016/j.jpsychires.2015.08.016. Epub 2015 Aug 29.

PMID:
26424428
17.

Predictors of Hypomania During Ventral Capsule/Ventral Striatum Deep Brain Stimulation.

Widge AS, Licon E, Zorowitz S, Corse A, Arulpragasam AR, Camprodon JA, Cusin C, Eskandar EN, Deckersbach T, Dougherty DD.

J Neuropsychiatry Clin Neurosci. 2016 Winter;28(1):38-44. doi: 10.1176/appi.neuropsych.15040089. Epub 2015 Sep 25.

18.

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study.

Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV.

Psychiatry J. 2015;2015:352979. doi: 10.1155/2015/352979. Epub 2015 Aug 19.

19.

Treatment Outcome in Depressed Latinos Predicted by Concomitant Psychosislike Symptoms.

Cassano P, Trinh NH, Chang T, Cusin C, Fisher L, Pedrelli P, Nyer M, Kim DJ, Alpert J, Mischoulon D.

J Nerv Ment Dis. 2015 Oct;203(10):769-73. doi: 10.1097/NMD.0000000000000365.

PMID:
26356091
20.

Test-retest reliability of freesurfer measurements within and between sites: Effects of visual approval process.

Iscan Z, Jin TB, Kendrick A, Szeglin B, Lu H, Trivedi M, Fava M, McGrath PJ, Weissman M, Kurian BT, Adams P, Weyandt S, Toups M, Carmody T, McInnis M, Cusin C, Cooper C, Oquendo MA, Parsey RV, DeLorenzo C.

Hum Brain Mapp. 2015 Sep;36(9):3472-85. doi: 10.1002/hbm.22856. Epub 2015 May 28.

Supplemental Content

Support Center